Coloplast A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLPBF research report →
Price Chart
About the company
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
- CEO
- Gavin Wood
- IPO
- 2000
- Employees
- 16,907
- HQ
- Humlebæk, ZE, DK
Get TickerSpark's AI analysis on CLPBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.17B
- P/E
- 35.55
- Fwd P/E
- 2.66
- PEG
- -1.10
- P/S
- 3.45
- P/B
- 7.35
- EV/EBITDA
- 10.32
- Div Yield
- 5.28%
- Gross Margin
- 58.50%
- Op Margin
- 26.35%
- Net Margin
- 9.71%
- ROE
- 19.69%
- ROIC
- 12.07%
Latest fiscal year · YoY change
- Revenue
- $27.82B+2.9%
- Gross Profit
- $18.10B-0.9%
- Op Income
- $7.57B
- Net Income
- $3.63B-28.2%
- EPS
- $16.10-28.3%
- OCF Growth
- +139.8%
- FCF Growth
- +275.3%
- 52W High
- $98.58
- 52W Low
- $56.81
- 50D MA
- $61.66
- 200D MA
- $72.86
- Beta
- 0.55
- RSI (14)
- 70
- Avg Volume
- 772
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the CLPBF Q3 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 68.9%
- Shares Outstanding
- 207.37M
- Float Shares
- 142.81M
Our CLPBF coverage
Recent articles, reports, and earnings notes.
No research on CLPBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLPBF report →Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says
reuters.com · Aug 18
Coloplast Might Have Found Its Bottom
seekingalpha.com · Aug 5
Coloplast: Went 'BUY' A Bit Early
seekingalpha.com · May 16
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript
seekingalpha.com · May 12
Coloplast: The Market Is Throwing Away A High-Quality Compounder
seekingalpha.com · Mar 17
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
globenewswire.com · Mar 11
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
globenewswire.com · Mar 8
Coloplast appoints Gavin Wood as new CEO
globenewswire.com · Mar 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.